Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Alpinetin ameliorates bone loss in LPS-induced inflammation osteolysis via ROS mediated P38/PI3K signaling pathway
Linhua Wei, Weiwei Chen, Linke Huang, et al.
Pharmacological Research (2022) Vol. 184, pp. 106400-106400
Closed Access | Times Cited: 50

Showing 26-50 of 50 citing articles:

Tumor Microenvironment Responsive RNA Drug Delivery Systems: Intelligent Platforms for Sophisticated Release
Guihua Wang, Mengxia Zhang, Weiwei Lai, et al.
Molecular Pharmaceutics (2024) Vol. 21, Iss. 9, pp. 4217-4237
Closed Access | Times Cited: 2
Corydaline attenuates osteolysis in rheumatoid arthritis via mitigating reactive oxygen species production and suppressing calcineurin-Nfatc1 signaling
Qizhen Lu, Haojue Wang, Xin Zhang, et al.
International Immunopharmacology (2024) Vol. 142, pp. 113158-113158
Closed Access | Times Cited: 2
Pyroptosis in Periprosthetic Osteolysis
Jian Yin, Zhaoyang Yin, Lai Peng, et al.
Biomolecules (2022) Vol. 12, Iss. 12, pp. 1733-1733
Open Access | Times Cited: 11
Cedrol, a Ginger-derived sesquiterpineol, suppresses estrogen-deficient osteoporosis by intervening NFATc1 and reactive oxygen species
Cong Xu, Shu-Qing Jin, Chen Jin, et al.
International Immunopharmacology (2023) Vol. 117, pp. 109893-109893
Closed Access | Times Cited: 6
Rapamycin Inhibits Osteoclastogenesis and Prevents LPS-Induced Alveolar Bone Loss by Oxidative Stress Suppression
Chong Feng, Yan Liu, Bao-Yi Zhang, et al.
ACS Omega (2023) Vol. 8, Iss. 23, pp. 20739-20754
Open Access | Times Cited: 6
Multifunctional photothermal PB@EGCG-Sr nanocoating design on titanium surface: To achieve short-term rapid osseointegration and on-demand photothermal long-term osteogenesis
Pengfei Gao, Yangpeng Zuo, Yulu Yang, et al.
Chemical Engineering Journal (2023) Vol. 474, pp. 145608-145608
Closed Access | Times Cited: 5
Eupatilin suppresses osteoclastogenesis and periodontal bone loss by inhibiting the MAPKs/Siglec-15 pathway
Boxuan Zhao, Zhiyong Chen, Ting Li, et al.
International Immunopharmacology (2024) Vol. 139, pp. 112720-112720
Closed Access | Times Cited: 1
Melatonin prevents bone loss in osteoporotic rats with valproic acid treatment by anti-inflammatory and anti-oxidative stress
Zhou-Shan Tao, Xu-Feng Hu, Tao Sun
International Immunopharmacology (2024) Vol. 141, pp. 112932-112932
Closed Access | Times Cited: 1
Albiflorin inhibits osteoclastogenesis and titanium particles-induced osteolysis via inhibition of ROS accumulation and the PI3K/AKT signaling pathway
Qiufei Wang, Huaqiang Tao, Heng Wang, et al.
International Immunopharmacology (2024) Vol. 142, pp. 113245-113245
Closed Access | Times Cited: 1
One arrow two eagles: multifunctional nano-system for macrophage reprogramming and osteoclastogenesis inhibition against inflammatory osteolysis
Tong Sha, Ze Wang, Jinwei Li, et al.
Materials Today Bio (2024) Vol. 29, pp. 101285-101285
Open Access | Times Cited: 1
AS-605240 Blunts Osteoporosis by Inhibition of Bone Resorption
Jiacheng Sun, Guoping Cai, Jinlong Shen, et al.
Drug Design Development and Therapy (2023) Vol. Volume 17, pp. 1275-1288
Open Access | Times Cited: 4
Myrislignan targets extracellular signal-regulated kinase (ERK) and modulates mitochondrial function to dampen osteoclastogenesis and ovariectomy-induced osteoporosis
Tao Yang, Weiwei Chen, Kai Gan, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 4
CB2 regulates oxidative stress and osteoclastogenesis through NOX1-dependent signaling pathway in titanium particle-induced osteolysis
Huaqiang Tao, Xueyan Li, Miao Chu, et al.
Cell Death Discovery (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 4
Layer-by-Layer Assembly of CeO2 Nanoparticle/Bovine Serum Albumin Films for Bone Regeneration
Shuoshuo Yang, Hailing Li, Zhonghong Gao
ACS Applied Nano Materials (2023) Vol. 6, Iss. 17, pp. 15697-15708
Closed Access | Times Cited: 3
A review on therapeutic mechanism of medicinal plants against osteoporosis: effects of phytoconstituents
Shilpa Kumari, Mohini Singh, Nupur Nupur, et al.
Molecular Biology Reports (2023) Vol. 50, Iss. 11, pp. 9453-9468
Closed Access | Times Cited: 3
Cichoric acid targets RANKL to inhibit osteoclastogenesis and prevent ovariectomy‐induced bone loss
Yansi Xian, Yijie Gao, Yiji Su, et al.
Phytotherapy Research (2024) Vol. 38, Iss. 4, pp. 1971-1989
Closed Access
Nanoparticulate bioceramic putty suppresses osteoclastogenesis and inflammatory bone loss in mice via inhibition of TRAF6‐mediated signalling pathways: A laboratory investigation
Zijun Wang, Jie Zhang, Xiaoyue Sun, et al.
International Endodontic Journal (2024) Vol. 57, Iss. 6, pp. 682-699
Closed Access
The effect of Nrf2 on bone resorption in chronic apical periodontitis
Qiyi Song, Saixuan Wu, Ming Dong, et al.
Research Square (Research Square) (2024)
Open Access
Active fraction of Polyrhachis vicina (Rogers) inhibits osteoclastogenesis by targeting Trim38 mediated proteasomal degradation of TRAF6
Xiaoliang Feng, Guining Wei, Yuangang Su, et al.
Phytomedicine (2024) Vol. 132, pp. 155890-155890
Closed Access
Protective effects of alpinetin against interleukin-1β-exposed nucleus pulposus cells: Involvement of the TLR4/MyD88 pathway in a cellular model of intervertebral disc degeneration
Junfeng Xia, Di Jia, Jianlong Wu
Toxicology and Applied Pharmacology (2024), pp. 117110-117110
Closed Access
Dauricine: Review of Pharmacological Activity
K Chen, Shuzhi Wang, Haibo Lei, et al.
Drug Design Development and Therapy (2024) Vol. Volume 18, pp. 4371-4385
Open Access
The Effects and Mechanisms of Chrysosplenetin in Targeting RANKL‐Induced NF‐κB Signaling and NFATc1 Activation to Protect Bone Density in Osteolytic Diseases
Guoju Hong, Lin Zhou, Wei He, et al.
Journal of Cellular Biochemistry (2024)
Closed Access
Damascenone Inhibits Osteoclastogenesis by Epigenetically Modulating Nrf2-Mediated ROS Scavenge and Counteracts OVX-Induced Osteoporosis
Qingliang Ma, Y. Xiong, Zhiwei Jie, et al.
Phytomedicine (2024) Vol. 135, pp. 156205-156205
Closed Access
Isoginkgetin inhibits RANKL-induced osteoclastogenesis and alleviates bone loss
Zihe Wang, Wei Deng, Kai Dun Tang, et al.
Biochemical Pharmacology (2024) Vol. 231, pp. 116673-116673
Closed Access
Multifunctional neuroimmunoregulatory nanoenzyme-enhanced hydrogel promotes bone regeneration by improving bone healing microenvironment
Qiujiang Li, Xingxia Long, Linnan Wang, et al.
Chemical Engineering Journal (2024) Vol. 504, pp. 158258-158258
Closed Access
Previous Page - Page 2

Scroll to top